ClinVar Miner

Submissions for variant NM_000543.5(SMPD1):c.1267C>T (p.His423Tyr)

gnomAD frequency: 0.00001  dbSNP: rs120074126
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 16
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000723415 SCV000700331 pathogenic not provided 2016-12-09 criteria provided, single submitter clinical testing
Invitae RCV000634570 SCV000755900 pathogenic Niemann-Pick disease, type B; Niemann-Pick disease, type A 2023-11-27 criteria provided, single submitter clinical testing This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 423 of the SMPD1 protein (p.His423Tyr). This variant is present in population databases (rs120074126, gnomAD 0.0009%). This missense change has been observed in individual(s) with Niemann-Pick disease (PMID: 12369017, 17876723, 27338287, 28600779). This variant is also known as p.His421Tyr. ClinVar contains an entry for this variant (Variation ID: 2992). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMPD1 protein function with a positive predictive value of 95%. This variant disrupts the p.His423 amino acid residue in SMPD1. Other variant(s) that disrupt this residue have been observed in individuals with SMPD1-related conditions (PMID: 16434659), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.
Pathology and Clinical Laboratory Medicine, King Fahad Medical City RCV000003126 SCV000996278 pathogenic Niemann-Pick disease, type B criteria provided, single submitter clinical testing Enzyme deficiency
Pathology and Clinical Laboratory Medicine, King Fahad Medical City RCV000411474 SCV000996279 pathogenic Niemann-Pick disease, type A criteria provided, single submitter clinical testing Enzyme deficiency
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000003126 SCV001339169 pathogenic Niemann-Pick disease, type B 2020-03-01 criteria provided, single submitter clinical testing Variant summary: SMPD1 c.1267C>T (p.His423Tyr) results in a conservative amino acid change located in the Acid sphingomyelinase/endophosphatase, metallophosphatase domain (IPR041805) of the encoded protein sequence. Two of four in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 249054 control chromosomes. c.1267C>T has been reported in the literature in multiple individuals affected with Niemann-Pick Disease (example, Fotoulaki_2007, Simonaro_2002) and has been cited by as one of the most common type B NPD allele among the Saudi population. These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity in both in-vitro and in-situ enzyme assays (Jones_2008). Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic (n=3)/likely pathogenic(n=1). Based on the evidence outlined above, the variant was classified as pathogenic.
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV000192225 SCV001422552 pathogenic Sphingomyelin/cholesterol lipidosis 2020-01-22 criteria provided, single submitter curation The p.His423Tyr variant in SMPD1 (also known as p.His421Tyr due to a difference in cDNA numbering) has been reported in at least 13 individuals with Niemann-Pick disease (PMID: 12369017, 27338287, 26981555, 17876723) and has been identified in 0.002% (1/66538) of European (non-Finnish) chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs120074126). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (VariationID: 2992) as likely pathogenic by Invitae and as pathogenic by Counsyl, EGL Genetic Diagnostics, OMIM and GeneReviews. In vitro functional studies provide some evidence that the p.His423Tyr variant may impact protein function (PMID: 18815062). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in at least 12 affected homozygotes and with another pathogenic variant in an affected individual increases the likelihood that the p.His423 variant is pathogenic (VariationID: 188840; PMID: 12369017, 27338287, 26981555, 17876723). The phenotype of an individual homozygous for this variant is highly specific for Niemann-Pick disease based on acid sphingomyelinase activity being <10% of normal, consistent with disease (PMID: 27338287, 17876723). The p.His423Tyr variant is located in a region of SMPD1 that is essential to protein folding and stability, suggesting that this variant is in a functional domain and supports pathogenicity (PMID: 12369017, 18815062). In summary, this variant meets criteria to be classified as pathogenic for Niemann-Pick disease in an autosomal recessive manner based on functional studies, its location in an active site and zinc binding site, its presence in affected homozygotes, and its presence in patients with a phenotype highly specific for disease. ACMG/AMP Criteria applied: PS3, PM2, PM1, PM3, PP3, PP4 (Richards 2015).
Baylor Genetics RCV000411474 SCV001524902 pathogenic Niemann-Pick disease, type A 2024-02-21 criteria provided, single submitter clinical testing
Diagnostics Division, CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS RCV000634570 SCV001738428 pathogenic Niemann-Pick disease, type B; Niemann-Pick disease, type A 2021-04-25 criteria provided, single submitter research
GeneDx RCV000723415 SCV001773482 pathogenic not provided 2019-05-14 criteria provided, single submitter clinical testing Published functional studies demonstrate a damaging effect (Jones et al., 2008); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; The majority of missense variants in this gene are considered pathogenic (Stenson et al., 2014); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 33101984, 32292456, 26981555, 26499107, 27338287, 28600779, 17876723, 20301544, 12369017, 18815062)
Revvity Omics, Revvity RCV000723415 SCV002020757 pathogenic not provided 2021-03-02 criteria provided, single submitter clinical testing
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics RCV000411474 SCV002575096 pathogenic Niemann-Pick disease, type A 2021-12-07 criteria provided, single submitter clinical testing A Heterozygous missense variation in exon 4 of the SMPD1 gene that results in the amino acid substitution of Tyrosine for Histidine at codon 423 was detected. The observed variant c.1267C>T (p.His423Tyr) has not been reported in the 1000 genomes and gnomAD databases. The in silico prediction of the variant are possibly damaging by DANN, FATHMM, PROVEAN. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as pathogenic.
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center RCV000411474 SCV004806496 pathogenic Niemann-Pick disease, type A 2024-03-26 criteria provided, single submitter clinical testing
OMIM RCV000003126 SCV000023284 pathogenic Niemann-Pick disease, type B 2002-12-01 no assertion criteria provided literature only
GeneReviews RCV000192225 SCV000238492 not provided Sphingomyelin/cholesterol lipidosis no assertion provided literature only Found most commonly in persons from Saudi Arabia. Leads to early-onset severe form of Niemann-Pick disease type-A
Counsyl RCV000003126 SCV000487210 pathogenic Niemann-Pick disease, type B 2016-10-26 no assertion criteria provided clinical testing
Natera, Inc. RCV000411474 SCV002092267 pathogenic Niemann-Pick disease, type A 2017-03-17 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.